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To prepare an antimicrobial polymer composite composed of silver- (Ag-) polyethyleneimine- (PEI-) polylactic acid (PLA) in
chloroform, for coating the mucosal surfaces of methacrylate-based dentures as a prospective therapy for denture stomatitis.
The water-insoluble, tightly bound, hard, micrometre-thin, and colourless ﬁlm exerts its eﬀects by direct contact with the
pathogens and via the active constituents (Ag, PEI, and Ag-PEI) released slowly into the mucosa’s salivary layer. Silver and PEI
were blended at 140°C, then bound to PLA. The Ag-PEI complex was characterised by dynamic light scattering and
transmission electron microscopy, and the Ag-PEI-PLA composite was examined by atomic force microscopy and micro-
computed tomography. The characteristic was measured by atomic force microscopy (AFM) and micro-computed tomography
(micro-CT). The quantity of water-soluble Ag-PEI complex released from the composite ﬁlm was measured with gravimetry.
The cellular physiological eﬀects were analysed by impedimetry and computer-based morphometry using human gingival
epithelial cells. A real-time cell proliferation assay revealed moderate toxic eﬀects of Ag-PEI on the epithelium. The viscous
Ag-PEI-PLA solution produced could be applied as a thin ﬁlm on methacrylate surfaces. Active antimicrobial components
(Ag, PEI, and Ag-PEI) were released from the hard, tightly bound Ag-PEI-PLA coating. This study’s ﬁndings veriﬁed the
applicability of the antimicrobial Ag-PEI-PLA composite for coating the inner surfaces of acrylate dentures. Owing to the
well-known antimicrobial eﬀects of silver and PEI and the supplementary eﬀects of chloroform, this composite provides a new
therapeutic method for denture stomatitis that can be easily performed by dentists.
1. Introduction
Denture stomatitis (also known as denture-related stomatitis,
candida-associated denture stomatitis, denture-associated
erythematous stomatitis, prosthetic stomatitis, or a combina-
tion of these terms) is a common, multifactorial condition in
which mild inﬂammation and erythema of the oral mucous
membrane occur under a removable prosthesis (i.e., a partial
or complete denture or an orthodontic appliance). In patients
having removable prostheses, the prevalence of denture
stomatitis ranges from 15% to >70%. The most important
etiological factors include ill-ﬁtting dentures, poor dental
hygiene, high carbohydrate intake, reduced salivary ﬂow, dia-
betes mellitus, and immune deﬁciency. Candida species are
oral fungal commensal organisms that are present in up to
90% of healthy individuals; Candida albicans is the most
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frequent fungal coloniser. Although denture stomatitis is not
a particularly severe illness in most cases, it may potentiate
additional infections in susceptible patients [1–7].
There is a large body of evidence that demonstrates that
Candida albicans is capable of adhering to polymethylmetha-
crylate (PMMA) surfaces to form a bioﬁlm. Microbial plaque
on the inner surfaces of dentures and the mucosa is com-
posed of bacteria and fungi. Changing the local environment
favours dominance of Candida and causes mucosal inﬂam-
mation; bacteria may support these inﬂammatory reactions.
Despite these relationships, most forms of therapy focus on
anti-Candida treatment [3, 8–10].
The treatment and management of denture stomatitis
can be focused locally and/or systemically. For patients with
poor compliance, diabetes, or who are immunocompro-
mised, systemic therapy is recommended. In the literature,
there are many diﬀerent forms and local application tech-
niques of antimicrobial agents reported, with very diverse
results. The most important issues include the development
of resistance and recurrent infections. Currently, there is no
“golden rule” for optimal therapy [11–15].
Our goal was to design an antimicrobial, hard polymer
composite for coating the inner surface of dentures. This
thin, polymer composite ﬁlm must comply with various
requirements: it should be biodegradable, release of the active
ingredients from the ﬁlm must be possible, it needs to be sol-
uble in a suitable solvent, and it must tightly bond to acrylate.
Another technical requirement is the easy and rapid prepara-
tion of a thin layer of the material by a dentist or the dental
laboratory. Although many polymers are used for coating,
the most common polymer, polylactic acid (PLA) dissolved
in chloroform, was chosen because of the fast and complete
elimination from the denture surface by evaporation.
We conceptualised that silver-polyethyleneimine (Ag-
PEI), with its core-shell micellar structure, excellent colloidal
stability, and easy method of hydrothermal synthesis, would
be the optimal active antimicrobial ingredient [16–18]. The
synergistic antibacterial eﬀect of silver with polyethylenei-
mine (PEI) has also been demonstrated [19, 20].
This Ag-PEI nanocomplex is water-soluble; therefore, it is
not suitable for acrylate coating on its own. To avoid this dis-
advantage, we needed to apply a polymer bulk material to
form a stable ﬁlm. We chose PLA, which can easily bind to
the Ag-PEI component by electric self-assembly (ESA) and
is nearly insoluble in water. The silver-polyethyleneimine-
polylactic acid (Ag-PEI-PLA) composite in chloroform is
capable of strongly binding to acrylate.
The objective of the present study was to develop an alter-
native form of therapy that approaches the problem from a
new aspect: to kill the pathogens with the Ag-PEI active
ingredient, while a suitable coating material simultaneously
solubilises the ﬁrst few superﬁcial micrometres of the acry-
late. For this purpose, chloroform promised to be the best sol-
vent in which the Ag-PEI and PLA solubilised equally well.
During the coating procedure, the ﬁrst few superﬁcial micro-
metres of acrylate will swell and become partially soluble
[21], which help kill the pathogens while embedding them.
After the chloroform rapidly evaporates, the composite
becomes a thin, hard, and colourless layer. The thickness of
this layer is between 30–40μm, which does not inﬂuence
the stability of the prosthesis. Considering the novel charac-
teristics of this form and application of the Ag-PEI-PLA
polymer composite, we propose the name “antimicrobial
hard lining” or “antimicrobial hard liner” for this form of
therapy and the composite.
Although the cytotoxic natures of Ag and PEI to bacteria
are well known, we analysed their biophysical eﬀects on the
human gingival epithelium (HGEP) using impedimetry.
Due to the electrical insulator moiety provided by the
phospholipid bilayer of the surface membrane, impedime-
try allowed us to analyse some basic cellular physiological
responses, including viability, cell adhesion, and cell prolif-
eration, induced by PEI and Ag-PEI.
The present paper discusses the synthesis and character-
isation of the Ag-PEI-PLA composite, including its toxicity
and adaptability in human therapy.
2. Materials and Methods
2.1. Materials. High-branched polyethyleneimine (PEI) with
a molecular weight of 25,000, silver nitrate (AgNO3), poly-
lactic acid (PLA) with a molecular weight of 60,000, and
chloroform were purchased from Sigma-Aldrich Chemie,
Germany; they were used in this study without further puri-
ﬁcation. Deionised and ultrapure water were used through-
out the study; their resistivity was ≥18MΩ cm.
2.2. Preparation of the Ag-PEI-PLA Polymer Composite. Dur-
ing the ﬁrst phase, the Ag-PEI complex, the “antimicrobial
active component,” was synthesised using a hydrothermal
method: 1 g of PEI was diluted in 2ml of deionised water
by stirring in a glass beaker; in another glass beaker, 158mg
of AgNO3 (100mg Ag) was diluted in 1ml of deionised water
by mild shaking the beaker. After the shaking, the solutions
were centrifuged for 10 minutes at 20,000g (Micromax RF,
Thermo Fisher Scientiﬁc, USA). The obtained solutions were
slowly uniﬁed in the PEI beaker by continuous stirring. The
yellowish solution was placed on the plate of a hot plate
stirrer (VELP Scientiﬁca, Italy) set at 90°C to evaporate the
water. During this process, a continuous darkening of the
sample to a deep brown colour and a reduction in its quantity
were observed. The temperature was then increased to 140°C;
the substance thickened, and the magnetic stir bar ceased
moving. Upon completion of this step, the sample was further
heated for 4 h, until it became a deep, dark greyish-brown,
thick mass. A dissolution test performed on the obtained
Ag-PEI sample proved that the prepared substance was
water- and chloroform-soluble [22, 23].
During the second phase, the PLA was conjugated to the
Ag-PEI complex by ESA. Two millilitres of 5% (w/v) PLA in
chloroform was added to 20mg of the Ag-PEI sample in a
glass tube. At this step, the honey-like, viscous Ag-PEI was
ﬁrst smeared onto the wall of the preweighted tube with a
spatula, then the mixture was intensely shaken for 30min
in a laboratory shaker (IKA Works, Wilmington, NC, USA).
The Ag-PEI was very easily solubilised in the 5% PLA solu-
tion, which turned yellowish-brown. Subsequently, a 30min
ultrasonic treatment was performed (45 kHz, 100W; Emmi
2 Journal of Nanomaterials
12HC, EMAG, Germany). The practically colourless super-
natant was gained with a 2min, 2000 rpm centrifugation
(BW41-BR230, Qualitron Inc., Korea), and the aggregated
pellet was discarded. The resultant substance was considered
suitable for coating acrylic surfaces [24, 25].
2.3. Atomic Force Microscopy of the Ag-PEI-PLA Composite.
TheAFMmeasurementswereperformedwith an atomic force
microscope (Dimension Icon, Bruker, Palaiseau, France) in
the tappingmode, under ambient conditions (relative humid-
ity, ~50%; temperature, ~22–24°C). The phase images from
the tapping mode operation are a map of how the phase of
cantilever oscillation is aﬀected by its interaction with the
surface. The physical meaning of this signal is complicated,
but in addition to topographic information, the phase can
be aﬀected by the relative softness/hardness or chemical
nature of the sample [26, 27]. For the tapping mode studies,
a cantilever (TESPA-V2, Bruker, Palaiseau, France) with a
spring constant of approximately 42N/m and resonance fre-
quencies of approximately 320 kHz was used.
2.4. Micro-Computed Tomography of the Ag-PEI-PLA
Composite. The Ag-PEI-PLA polymer composite ﬁlm was
scanned using a micro-computed tomography device (Sky-
Scan 1172 microCT, Bruker, Kontich, Belgium). The acquisi-
tion parameters were as follows: a 1.91 μm isometric cube
voxel with no ﬁlter, at 40 kV, with a 200 μA tube current.
The rotation step was 0.5°. From the raw image data set,
3D-rendered images were constructed using CTAn and
CTVol software (Bruker, Kontich, Belgium).
2.5. Weight Changes of the Ag-PEI-PLA Composite after 8
Days of Distilled Water (DW) Storage. Fourteen-centimetre-
squared portions of PMMA microscopic slides (26× 76mm)
were coated with 1–1ml of the Ag-PEI-PLA composite and
PLA in chloroform. After evaporation of the chloroform,
the dried slides were placed into DW for 8 days. The weight
changes of the air-dried slides were measured on days 1, 2,
3, 4, 5, and 8 with an analytic balance.
2.6. Size Measurement of the Nanoparticles Released from the
Polyethyleneimine-Polylactic Acid (PEI-PLA) and Ag-PEI-
PLA Membranes. Thin polymer membranes were prepared
by casting on a glass surface and pulling out carefully. The
compositions of PEI-PLA and Ag-PEI-PLAmembranes were
identical to those described above. Three cut pieces from
both types of membranes (area, 1 cm2; thickness, 0.05mm)
were immersed in 5–5ml cell culture media free of fetal
bovine serum (FBS), representing identical extraction times.
Samples (1.5ml) containing the released particles were col-
lected on day 1, day 5, and day 10 (D1, D5, and D10,
respectively). The sizes of the nanoparticles released from
the PEI-PLA and Ag-PEI-PLA membranes were measured
using a Zetasizer Nano S instrument (Malvern Instruments
Ltd., Malvern, UK).
2.7. Impedimetry
2.7.1. Model Cells. Cultures of the HGEP cell line (CELLn-
TEC, Bern, Swiss) were maintained in CnT-24.S medium
(CELLnTEC, Bern, Swiss) containing 1% L-glutamine and
supplementedwith 1%penicillin-streptomycin (LonzaGroup
Ltd., Switzerland).
The cell cytotoxic and adhesion eﬀects of the PEI-PLA
and Ag-PEI-PLA extracts were investigated with a xCELLi-
gence RTCA SP (ACEA Biosciences Inc., San Diego, USA)
impedance-based system. The real-time assays were imple-
mented in E-plate 96 arrays (ACEA Biosciences Inc., San
Diego, USA) with a 15 kHz AC system, using a 20 s sampling
frequency on noncoated electrodes.
2.7.2. Cytotoxicity Assay. First, growth of a conﬂuent culture
of HGEP cells was controlled by impedimetry in the wells of
the E-plate 96 arrays. After 24h, the cultures were treated
with the 1- or 5-day PEI-PLA or Ag-PEI-PLA membrane
extracts (dilutions: 1000x, 100x, 10x, and 1x) for 168 h.
2.7.3. Cell Adhesion Assay. First, the impedance of the culture
medium was recorded as a baseline and absolute control.
Second, the HGEP cells were loaded together with extracts
of PEI-PLA or Ag-PEI-PLA (dilutions: 1000x, 100x, 10x,
and 1x) prepared by soaking the composite membrane in cell
culture medium for 1 or 5 days. The follow-up time was 12 h.
2.8. Apoptosis Measurement. In the background of the cyto-
toxic eﬀects, induction of apoptotic processes is frequently
revealed. In the present study, our objective was to detect
early apoptotic events. The ratio of apoptotic HGEP cells
was evaluated after 24 h of treatment with the PEI-PLA and
Ag-PEI-PLA composite extracts. For this purpose, two inde-
pendent apoptosis assays were performed: (i) computer-
based morphometry analysis of HGEP cells treated with the
composite extracts and (ii) annexin V staining which is a
well-known indicator of the disturbed surface membrane
asymmetry, a chief early marker of apoptosis. Computer-
based evaluation of the dead cell number on micrograph
series taken by light microscopy (obj.: 20x; Axio Observer
A1; Carl Zeiss Microscopy GmbH, Jena, Germany) was done
by Fiji ImageJ software [28]. The early phase of apoptosis was
detected using annexin V labelling (PE Annexin V, BioLe-
gend, San Diego, USA) and was measured by ﬂow cytometry
(FACSCalibur, BD Biosciences, NJ, USA).
2.9. Statistical Analysis. The delta CI (ΔCI) and slope values
were calculated by the integrated software (RTCA 1.2, Roche
Applied Science, Indianapolis, IN, USA) of xCELLigence SP
System. For the further analysis of the data, the Origin Pro
8.0 (OriginLab Corporation, Northampton, MA, USA) sta-
tistical program was used. Data shown in the ﬁgures repre-
sent mathematical averages of three parallels and ±SD
values. Statistical analysis of data was done by the application
of ANOVA of Origin Pro 8.0. The level of signiﬁcance is
shown as follows: x: P < 0 05; y: P < 0 01; z: P < 0 001.
3. Result
3.1. Weight Changes of the Composite after 8 Days of DW
Storage. Initially, the average weights of the Ag-PEI-PLA
and the control PLA layers prepared on the microscopic glass
slides were 57.58mg and 58.76mg, respectively. After 8 days,
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the weights of both the composite and PLA ﬁlm had
decreased, but the weight lost from the composite was signif-
icantly higher than that of the PLA ﬁlm (33% and 11%,
respectively, on day 8; Figure 1).
3.2. Size of the Nanoparticles Released from the PEI-PLA and
Ag-PEI-PLA Membranes. Figure 2 presents the size distribu-
tion analyses of the particles released from the PEI-PLA and
Ag-PEI-PLA membranes and demonstrates that they have
characteristic proﬁles containing populations of particles
signiﬁcantly diﬀerent from that of the control (medium). A
time-course analysis of the peaks shows a decrease with time
(Ag-PEI-PLA: D1, 7 nm; D5, 6 nm; D10, 4 nm); nevertheless,
no signiﬁcant diﬀerence was detectable in the PEI- vs. Ag-
PEI-containing preparations in relation to the duration of
the study (data not shown).
3.3. Atomic Force Microscopy of the Ag-PEI-PLA Composite.
The pseudo-3D images of the height data show spherical
shapes in the range of 0.5–4.0 μm (Figures 3(b) and 3(d)).
In this case, the phase images were primarily determined by
the topographic structure on the thin ﬁlm surface. The phase
images provided better contrast than the height images
(Figures 3(a) and 3(c)).
3.4. Micro-Computed Tomography of the Ag-PEI-PLA
Composite. At the maximum enlargement provided by our
micro-CT instrument, a granular structure of the composite
was evident, indicating the aggregation process (Figure 4).
3.5. Impedimetry
3.5.1. Cytotoxicity. The toxic eﬀects elicited by the nanoparti-
cles released from the PEI-PLA and Ag-PEI-PLA were evalu-
ated in the day 1 and day 5 samples. The eﬀects of the 1/10
serial dilutions in the range of 1000x–1x were analysed
by impedimetry over a 0–168h period. As depicted in
Figure 5, the day 1 samples were capable of eliciting strong
and durable cytotoxic eﬀects in the HGEP cells. The cytotoxic
sensibility of the HGEP cells proved to be greater to the PEI-
PLA D1 extracts (dilution range, 100x–1x) than the Ag-PEI-
PLA extracts (dilution range, 10x–1x). For the day 5 extracts
(data not shown), the cytotoxic characters of both types of
extracts were still detectable; however, the amplitude of
toxicity in the PEI-PLA extract was similar to that of the
Ag-PEI-PLA extract.
3.5.2. Cell Adhesion. Comparison of the adhesion blocker
abilities (Figure 5) demonstrated that both the PEI-PLA
and Ag-PEI-PLA day 1 extracts had a signiﬁcant blocking
eﬀect (dilution ranges: 1x–10x); however, the eﬀect of the
PEI-PLA extract was more pronounced than that of the
Ag-PEI-PLA extract.
3.6. Apoptosis. Our data revealed that both the day 1 and day
5 PEI-PLA and Ag-PEI-PLA extract samples resulted an
increased number of dead cells (Table 1) as well as annexin
V signals (Figure 6). A comparison of the apoptotic eﬀects
elicited by the nanoparticles derived from the PEI-PLA and
Ag-PEI-PLA extracts indicated that PEI alone had the
strongest and widest range (100x–10x) eﬀect, while in
Ag-PEI, only 10x dilutions were eﬀective.
4. Discussion
Our goal was to extend the possibilities for the management
and therapy of denture stomatitis beyond conventional
methods. The aim of this study was to produce a thin, hard
ﬁlm on the mucosal surface of acrylate dentures that has anti-
microbial eﬀects. Beyond the advantageous on contact killing
property of this hard antimicrobial surface, this ﬁlm has
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period. Technical parameters of the assay—sample number: 16;
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Figure 2: Size distribution of the day 1 polyethyleneimine-
polylactic acid (PEI-PLA) and silver-polyethyleneimine-polylactic
acid (Ag-PEI-PLA) extracts (medians: PEI-PLA extract, 4.8; Ag-
PEI-PLA extract, 5.6). The detected diﬀerence indicates that the
size of the silver-containing PEI-PLA particles was signiﬁcantly
larger (P = 0 05) than that of the PEI-PLA particles. Technical
parameters of the assay—sample number: 3; temperature: 25°C;
time: 60 s.
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additional eﬀects owing to the release of active components.
For easy application of the polymer composite on the inner
surfaces of prostheses, it is necessary for it to have a suitable
viscosity and rapid evaporation of the solvent and be insolu-
ble or very slow to solubilise in water.
The presented work is focused on basic research, dealing
with in vitro assays; nevertheless, authors complement it
with some recommendations for the clinical usage. The
application of this hard antimicrobial liner is very similar
to the application of the adhesive layer used in the classical
relining procedure of dentures by brush. After the evapora-
tion, a longer storage in water can induce the release of the
active complex.
The silver nanoparticles, which have some unique prop-
erties, play a central role in antibacterial and antifungal ther-
apies [29]. The eﬀectiveness of these nanoparticles depends
on the performance of adequate laboratory procedures dur-
ing preparation [29–33]. There are more than one hundred
reports regarding the combination of silver with diﬀerent sta-
bilisers, including polymers like polyethyleneimine, while
avoiding strong aggregation [17, 18, 19, 34, 35]. All the
authors used several alterations, but the basic steps of synthe-
sis include the reduction of silver and inhibition of aggrega-
tion, followed by functionalization for a given role. The
antimicrobial eﬀectiveness primarily depends on the size of
the nanoparticles [36, 37].
The method used in the present study uses an easy and
common form of synthesis, with mild reduction and aggrega-
tion inhibition by PEI. The dense Ag-PEI complex is suitable
for long-term storage, and a new sample can be easily pre-
pared at chairside for application. According to generally
accepted professional opinion, the smaller silver clusters or
aggregates provide higher antimicrobial eﬀects [36, 37]. In
our composite, the PEI was used for three purposes: (1) the
cationic polymer’s antimicrobial eﬀect, (2) the colloidal sta-
bility of nanosilver, and (3) the reduction of silver ions in
the AgNO3 solution. The antimicrobial eﬀects of Ag and
PEI are well known, both individually and in combinations
[20, 38–40].
For coating purposes, instead of the denture material
(PMMA) which is nonbiodegradable, PLA was used in
compliance with the previously stated requirements: it is
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biodegradable, soluble in chloroform, and easily binds to
the Ag-PEI nanoparticles by ESA. Several methods are
available for preparation of the PEI-PLA copolymer, and
diﬀerent polymer combinations are available for drug deliv-
ery systems [41–44].
Additionally, the solubilising agent, chloroform, has an
antipathogenic eﬀect. It is one of the strongest permeabilising
organic solvents with antipathogenic eﬀects on Candida albi-
cans [45, 46], and it facilitates intake of active components
(e.g., Ag and PEI) into the bacterial and fungal cells. Another
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Table 1: Computer-assisted morphometry of apoptosis induced by polyethyleneimine-polylactic acid (PEI-PLA) and silver-
polyethyleneimine-polylactic acid (Ag-PEI-PLA) extracts. D1: day 1; D5: day 5; and D10: day 10 extractions. Serial dilutions of 1/10,
range: 1000x–10x. Control (Cont) in HGEP cells.
Number of apoptotic
cells [±SD] P Apoptosis
Number of apoptotic
cells [±SD] P Apoptosis
PEI-PLA Ag-PEI-PLA
Control 1± 0.32 1± 0.54
D1—10x 103± 3.21 0.001 +++ 20± 2.33 0.01 +
D1—100x 37± 2.14 0.01 + 1± 0.24
D1—1000x 3± 0.44 1± 0.31
D5—10x 86± 3.03 0.001 ++ 24± 3.67 0.01 +
D5—100x 48± 3.61 0.01 + 2± 0.78
D5—1000x 3± 0.38 1± 0.12
D10—10x 70± 4.70 0.01 ++ 45± 4.11 0.01 +
D10—100x 35± 3.63 0.01 + 4± 0.41
D10—1000x 2± 0.15 1± 0.09
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important property of chloroform is that it is a weak hydro-
gen donor, which may inﬂuence the ESA and the release of
components [47, 48].
The Ag+ mild and PEI have medium cytotoxic eﬀects,
respectively. All antimicrobial agents have some degree of
cytotoxic eﬀect. The degree of cytotoxicity depends on the
sensitivity of the microbial species, the characteristics of the
environment, and in our study, the modiﬁcation of agents,
notably PEI. The cytotoxicity of PEI depends on the number
of reactive amino groups at the free terminals of the chains
[49]. Forming complexes with Ag+, the number of free PEI
amino groups will decrease. Our comparative evaluation of
the extracts revealed that the Ag-PEI-PLA extract had signif-
icantly less cytotoxic eﬀects than the derivative PEI-PLA
extract containing no silver. The time course evaluation of
nanoparticle release (day 1, day 5, and day 10) also demon-
strated that over a long period, the Ag-PEI-PLA extract is
more advantageous, as it has less apoptosis induction ability.
To summarise, the cell biology analysis data show that
the nanosilver-containing novel composite (Ag-PEI-PLA)
is better tolerated by the cells of the superﬁcial layers of
the oral cavity.
One of the most important clinical requirements of this
study was to achieve an antimicrobial eﬀect that extended
beyond a week. For practical application of our composite,
we need to know when the coating layer partially or
completely disappears from the PMMA surface. In a pilot
experiment, we measured the weight changes of the compos-
ite- and PLA-coatings alone as controls after storage in DW.
Theoretically, the water-soluble Ag-PEI active component
should release ﬁrst. The micellar structure and nanospaces
between its individual elements allow the possibility of a slow
release of diﬀerent components via diﬀusion. This phenome-
non may also assist PLA degradation, which is a very slow
process. In the literature, there are no data reported regarding
the interaction between the individual parts of the composite,
or in our case, between PLA and PEI on release.
Over the antibacterial contact killing, the eﬀect of the
released components is also notable. As demonstrated in
Figure 1, the weight of our composite decreased over the 1–
8-day period was 33.69%. This result was signiﬁcantly higher
than the PLA release. According to our concept, the PLA,
through ESA, decreased the solubility of the PEI or Ag-PEI.
The ratio of the PLA and active components will inﬂuence
the rate of release. These data indicate that the composite’s
weight loss was greater than the entire Ag-PEI content
(mean, 16.67%) in the composite sample. It is possible that
the released substance was a mix of the components. From
another perspective, the weak hydrogen bonding of the sol-
vent (chloroform) may inﬂuence the physical properties of
the polymers and decrease the molecular mobility [47, 48].
The antimicrobial eﬀects of silver and PEI are well
known, but the exact, detailed analysis of the Ag-PEI-PLA
composite on the diﬀerent pathogens of oral cavity is neces-
sary to be studied. Investigation of the composite is planned
to be extended in microbiology and clinical practice.
Further research is required to investigate the viability of
the pathogens in the deeper layers of the microcracks covered
by the microbial ﬁlm and to determine the potential eﬀects
caused by the modiﬁcation of surface roughness.
5. Conclusions
In this study, a new method was presented for consideration
as a novel antimicrobial surface-modifying substance for
managing denture stomatitis. The essence of the method
was to prepare a nanosilver-PEI-PLA substance, in chloro-
form, for coating the mucosal surface of removable dental
prostheses. The antimicrobial eﬀects are exerted primarily
by Ag and PEI. Additionally, the chloroform had a solubilis-
ing eﬀect on the thin, upper acrylate layer of the prosthesis,
which may enhance the antimicrobial eﬀects by permeabilis-
ing the pathogenmembranes. The authors are convinced that
this new method, including its multiple combined antimicro-
bial eﬀects, provides an opportunity to introduce an eﬀective,
novel candidate for managing denture stomatitis. Further,
this application procedure could be easily performed chair-
side by dentists.
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